Vertical Sleeve Gastrectomy inhibits 11βHSD1 and subsequently reduces IL6 secretion in Mice and Humans: A Shared Anti-Inflammatory Mechanism
Journal of Endocrinology · 29.10.2026
DOI: 10.1530/joe-26-0189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, online erschienen am 29.10.2026. Verfasst von Shiyi Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduc…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vertical sleeve gastrectomy (VSG) improves glycaemic control in type 2 diabetes (T2D) through mechanisms that extend beyond weight loss. The interaction between glucocorticoid metabolism and inflammation in this context remains unclear.
Methods
We investigated the role of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in mediating the metabolic effects of VSG in humans and mice. Subcutaneous adipose tissue biopsies were collected before and 6 months after VSG. Parallel studies were conducted in lean and high-fat diet-fed mice undergoing VSG or sham surgery, alongside 11βHSD1 knockout models. Glucose tolerance and expression of 11βHSD1 and interleukin-6 (IL6) were assessed.
Results
VSG reduced 11βHSD1 and IL6 expression in human adipose tissue and improved insulin resistance. In lean mice, VSG reduced adipose Hsd11b1 and Il6 expression and altered glucose handling in the absence of detectable changes in total body weight. 11βHSD1 knockout mice exhibited improved glucose tolerance despite increased body weight, partially recapitulating the VSG phenotype. Both interventions reduced circulating and tissue IL6 levels.
Conclusions
These findings identify an association between reduced 11βHSD1, inflammatory signalling and metabolic adaptations following VSG, and support further investigation of 11βHSD1 as a potential contributor to the metabolic effects of surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.
- The Roger Williams Institute of Hepatology, Foundation for Liver Research , London, United Kingdom.
- Faculty of Life Sciences and Medicine, King's College London , London, United Kingdom.
- School of Medicine, Faculty of Life & Health Sciences, Ulster University , Ulster, Norther Ireland, UK.
- Department of Cardiovascular Sciences, College of Life Sciences, University of Leicester , Leicester, United Kingdom.
ORCID-Profile: Elina Akalestou
Zitieren
APA
Liang, S., Samarasinghe, S., Johnson, B., Wang, W., Durazzo, I. D., Tsou, P., Riva, A., Miras, A., & Akalestou, E. (2026). Vertical Sleeve Gastrectomy inhibits 11βHSD1 and subsequently reduces IL6 secretion in Mice and Humans: A Shared Anti-Inflammatory Mechanism. Journal of Endocrinology. https://doi.org/10.1530/joe-26-0189
Vancouver
Liang S, Samarasinghe S, Johnson B, Wang W, Durazzo ID, Tsou P, et al. Vertical Sleeve Gastrectomy inhibits 11βHSD1 and subsequently reduces IL6 secretion in Mice and Humans: A Shared Anti-Inflammatory Mechanism. Journal of Endocrinology. 2026. doi:10.1530/joe-26-0189
BibTeX
@article{Liang2026,
author = {Liang, Shiyi and Samarasinghe, Suhanya and Johnson, Brett and Wang, Wenya and Durazzo, Isabella Doria and Tsou, Phoebe and Riva, Antonio and Miras, Alex and Akalestou, Elina},
title = {Vertical Sleeve Gastrectomy inhibits 11βHSD1 and subsequently reduces IL6 secretion in Mice and Humans: A Shared Anti-Inflammatory Mechanism},
journal = {Journal of Endocrinology},
year = {2026},
doi = {10.1530/joe-26-0189}
}
EUVIMED